Orexo AB Release: Letter to Shareholders From Chairman Martin Nicklasson

Published: Jul 19, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Uppsala, Sweden – June 19, 2013 - A letter to shareholders has been sent to all shareholders of Orexo AB and is a summary of the most important milestone achieved, the approval of Zubsolv and the forthcoming plans for the product by the Chairman of Orexo, Martin Nicklasson. The letter is also available on the company's home page at www.orexo.com.

Help employers find you! Check out all the jobs and post your resume.

Back to news